Chance of light to moderate rain over Islands and some eastern and western areas
uae3 hours ago
Pfizer has started an early-stage US trial of an oral Covid-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on Tuesday.
The drugmaker, which developed the first authorised coronavirus vaccine in the US with Germany's BioNTech SA, said the antiviral candidate showed potent activity against SARS-CoV-2, the virus that causes COVID-19, in lab studies.
Pfizer's candidate, named PF-07321332, is a protease inhibitor that prevents the virus from replicating in cells.
Protease inhibitors have been effective at treating other viral pathogens such as HIV and hepatitis C virus, both on their own and in combination with other antivirals, the company said.
Pfizer believes this class of molecules may provide well-tolerated treatments against Covid-19, as currently marketed therapeutics that work on the same lines have not reported safety concerns.
The company is also studying an intravenously administered antiviral candidate in an early-stage trial in hospitalized COVID-19 patients.
"Together, the two (oral and intravenous candidates) have the potential to create an end-to-end treatment paradigm that complements vaccination in cases where disease still occurs," Pfizer's Chief Medical Officer Mikael Dolsten said in a statement.
Pfizer's candidate is behind two other oral antiviral therapies, which are in mid-stage trials – the first being developed by rival Merck & Co with Ridgeback Bio, and a second from Roche Holding and Atea Pharmaceuticals.
Gilead Sciences' remdesivir is currently the only US Food and Drug Administration-approved drug for the treatment of COVID-19.
The FDA has granted an emergency authorization to intravenous therapies from Eli Lilly - bamlanivimab alone and in combination with etesevimab, and a combination therapy from Regeneron.
Chance of light to moderate rain over Islands and some eastern and western areas
uae3 hours ago
Bollywood star Katrina Kaif talks about the power of being comfortable in your own skin as Kay Beauty, a brand she co-founded with Nykaa, makes its way to the UAE
entertainment4 hours ago
DXB will continue to serve as the primary hub over the next few years as the DWC expansion takes shape
aviation4 hours ago
Demand for comprehensive insurance packages jumps 100% as third-party plans don’t cover damages due to natural disaster
uae4 hours ago
Avoid flooded roads, but follow these tips to navigate them safely if you have no other option
uae4 hours ago
All relevant agencies are prepared to tackle the anticipated weather fluctuations by implementing proactive measures
uae4 hours ago
The cows involved in this project are not medically inseminated or treated
uae4 hours ago
Concerned authorities in Dubai confirm their readiness to deal with the prevailing conditions
uae10 hours ago